Man Group PLC Cytokinetics Inc Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Man Group PLC holds 75,139 shares of CYTK stock, worth $4.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

75,139

Previous 82,644 9.08%

Holding current value

$4.2 Million

Previous $5.79 Million 29.74%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $359,189 - $563,250	-7,505 Reduced 9.08%	75,139 $4.07 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $4.74 Million - $8.04 Million	74,357 Added 897.27%	82,644 $5.79 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $48,948 - $152,035	-1,821 Reduced 18.02%	8,287 $691,000
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $6.89 Million - $8.57 Million	-233,999 Reduced 95.86%	10,108 $297,000
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $4.28 Million - $5.35 Million	131,341 Added 116.47%	244,107 $7.96 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $3.76 Million - $5.15 Million	112,766 New	112,766 $3.97 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $1.15 Million - $1.65 Million	33,820 Added 64.23%	86,473 $3.4 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $1.57 Million - $2.42 Million	52,653 New	52,653 $1.94 Million
Q1 2019 May 15, 2019	SELL	$5.95 - $10.19 $66,045 - $113,109	-11,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$5.91 - $9.29 $13,593 - $21,366	-2,300 Reduced 17.16%	11,100 $70,000
Q3 2018 Nov 14, 2018	SELL	$6.4 - $9.85 $31,360 - $48,265	-4,900 Reduced 26.78%	13,400 $132,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $235,980 - $338,580	-34,200 Reduced 65.14%	18,300 $152,000
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $378,000 - $527,625	52,500 New	52,500 $378,000

Others Institutions Holding CYTK

# of Institutions

415

Shares Held

127M

Call Options Held

3.41M

Put Options Held

2.16M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.27B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account